Browse > Article
http://dx.doi.org/10.5230/jgc.2014.14.3.147

The Role of Gastrokine 1 in Gastric Cancer  

Yoon, Jung Hwan (Department of Pathology, College of Medicine, The Catholic University of Korea)
Choi, Won Suk (Department of Pathology, College of Medicine, The Catholic University of Korea)
Kim, Olga (Department of Pathology, College of Medicine, The Catholic University of Korea)
Park, Won Sang (Department of Pathology, College of Medicine, The Catholic University of Korea)
Publication Information
Journal of Gastric Cancer / v.14, no.3, 2014 , pp. 147-155 More about this Journal
Abstract
Homeostatic imbalance between cell proliferation and death in gastric mucosal epithelia may lead to gastritis and gastric cancer. Despite abundant gastrokine 1 (GKN1) expression in the normal stomach, the loss of GKN1 expression is frequently detected in gastric mucosa infected with Helicobacter pylori, as well as in intestinal metaplasia and gastric cancer tissues, suggesting that GKN1 plays an important role in gastric mucosal defense, and the gene functions as a gastric tumor suppressor. In the stomach, GKN1 is involved in gastric mucosal inflammation by regulating cytokine production, the nuclear factor-${\kappa}B$ signaling pathway, and cyclooxygenase-2 expression. GKN1 also inhibits the carcinogenic potential of H. pylori protein CagA by binding to it, and up-regulates antioxidant enzymes. In addition, GKN1 reduces cell viability, proliferation, and colony formation by inhibiting cell cycle progression and epigenetic modification by down-regulating the expression levels of DNMT1 and EZH2, and DNMT1 activity, and inducing apoptosis through the death receptor-dependent pathway. Furthermore, GKN1 also inhibits gastric cancer cell invasion and metastasis via coordinated regulation of epithelial mesenchymal transition-related protein expression, reactive oxygen species production, and PI3K/Akt signaling pathway activation. Although the modes of action of GKN1 have not been clearly described, recent limited evidence suggests that GKN1 acts as a gastricspecific tumor suppressor. This review aims to discuss, comment, and summarize the recent progress in the understanding of the role of GKN1 in gastric cancer development and progression.
Keywords
GKN1 protein; Homeostasis; Gastritis; Stomach neoplasms; Tumor suppressor gene;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Hall PA, Coates PJ, Ansari B, Hopwood D. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci 1994;107:3569-3577.
2 Baus-Loncar M, Lubka M, Pusch CM, Otto WR, Poulsom R, Blin N. Cytokine regulation of the trefoil factor family binding protein GKN2 (GDDR/TFIZ1/blottin) in human gastrointestinal epithelial cells. Cell Physiol Biochem 2007;20:193-204.   DOI
3 Babyatsky MW, deBeaumont M, Thim L, Podolsky DK. Oral trefoil peptides protect against ethanol- and indomethacininduced gastric injury in rats. Gastroenterology 1996;110:489-497.   DOI   ScienceOn
4 Toback FG, Walsh-Reitz MM, Musch MW, Chang EB, Del Valle J, Ren H, et al. Peptide fragments of AMP-18, a novel secreted gastric antrum mucosal protein, are mitogenic and motogenic. Am J Physiol Gastrointest Liver Physiol 2003;285:G344-G353.   DOI   ScienceOn
5 Martin TE, Powell CT, Wang Z, Bhattacharyya S, Walsh-Reitz MM, Agarwal K, et al. A novel mitogenic protein that is highly expressed in cells of the gastric antrum mucosa. Am J Physiol Gastrointest Liver Physiol 2003;28:G332-G343.
6 Shiozaki K, Nakamori S, Tsujie M, Okami J, Yamamoto H, Nagano H, et al. Human stomach-specific gene, CA11, is downregulated in gastric cancer. Int J Oncol 2001;19:701-707.
7 Westley BR, Griffin SM, May FE. Interaction between TFF1, a gastric tumor suppressor trefoil protein, and TFIZ1, a brichos domain-containing protein with homology to SP-C. Biochemistry 2005;44:7967-7975.   DOI   ScienceOn
8 Menheniott TR, Kurklu B, Giraud AS. Gastrokines: stomachspecific proteins with putative homeostatic and tumor suppressor roles. Am J Physiol Gastrointest Liver Physiol 2013;304:G109-G121.   DOI   ScienceOn
9 Hedlund J, Johansson J, Persson B. BRICHOS - a superfamily of multidomain proteins with diverse functions. BMC Res Notes 2009;2:180.   DOI   ScienceOn
10 Sanchez-Pulido L, Devos D, Valencia A. BRICHOS: a conserved domain in proteins associated with dementia, respiratory distress and cancer. Trends Biochem Sci 2002;27:329-332.   DOI   ScienceOn
11 Yoon JH, Choi YJ, Choi WS, Nam SW, Lee JY, Park WS. Functional analysis of the NH2-terminal hydrophobic region and BRICHOS domain of GKN1. Biochem Biophys Res Commun 2013;440:689-695.   DOI   ScienceOn
12 Nardone G, Rippa E, Martin G, Rocco A, Siciliano RA, Fiengo A, et al. Gastrokine 1 expression in patients with and without Helicobacter pylori infection. Dig Liver Dis 2007;39:122-129.   DOI   ScienceOn
13 Moss SF, Lee JW, Sabo E, Rubin AK, Rommel J, Westley BR, et al. Decreased expression of gastrokine 1 and the trefoil factor interacting protein TFIZ1/GKN2 in gastric cancer: influence of tumor histology and relationship to prognosis. Clin Cancer Res 2008;14:4161-4167.   DOI   ScienceOn
14 Yoon JH, Song JH, Zhang C, Jin M, Kang YH, Nam SW, et al. Inactivation of the Gastrokine 1 gene in gastric adenomas and carcinomas. J Pathol 2011;223:618-625.   DOI   ScienceOn
15 Yoon JH, Choi YJ, Choi WS, Ashktorab H, Smoot DT, Nam SW, et al. GKN1-miR-185-DNMT1 axis suppresses gastric carcinogenesis through regulation of epigenetic alteration and cell cycle. Clin Cancer Res 2013;19:4599-4610.   DOI   ScienceOn
16 Xing R, Li W, Cui J, Zhang J, Kang B, Wang Y, et al. Gastrokine 1 induces senescence through p16/Rb pathway activation in gastric cancer cells. Gut 2012;61:43-52.   DOI   ScienceOn
17 Sharma SA, Tummuru MK, Blaser MJ, Kerr LD. Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J Immunol 1998;160:2401-2407.
18 Rippa E, La Monica G, Allocca R, Romano MF, De Palma M, Arcari P. Overexpression of gastrokine 1 in gastric cancer cells induces Fas-mediated apoptosis. J Cell Physiol 2011;226:2571-2578.   DOI   ScienceOn
19 Guang W, Ding H, Czinn SJ, Kim KC, Blanchard TG, Lillehoj EP. Muc1 cell surface mucin attenuates epithelial inflammation in response to a common mucosal pathogen. J Biol Chem 2010;285:20547-20557.   DOI   ScienceOn
20 Isomoto H, Mizuta Y, Miyazaki M, Takeshima F, Omagari K, Murase K, et al. Implication of NF-kappaB in Helicobacter pylori-associated gastritis. Am J Gastroenterol 2000;95:2768-2776.
21 Kang MJ, Ryu BK, Lee MG, Han J, Lee JH, Ha TK, et al. NFkappaB activates transcription of the RNA-binding factor HuR, via PI3K-AKT signaling, to promote gastric tumorigenesis. Gastroenterology 2008;135:2030-2042.   DOI   ScienceOn
22 Liu CA, Wang MJ, Chi CW, Wu CW, Chen JY. Rho/Rhotekinmediated NF-kappaB activation confers resistance to apoptosis. Oncogene 2004;23:8731-8742.   DOI   ScienceOn
23 Yoon JH, Cho ML, Choi YJ, Back JY, Park MK, Lee SW, et al. Gastrokine 1 regulates NF-$\kappa$B signaling pathway and cytokine expression in gastric cancers. J Cell Biochem 2013;114:1800-1809.   DOI   ScienceOn
24 Wang D, Dubois RN. Eicosanoids and cancer. Nat Rev Cancer 2010;10:181-193.   DOI   ScienceOn
25 Ikeguchi M, Hatada T, Yamamoto M, Miyake T, Matsunaga T, FukumotoY, et al. Serum interleukin-6 and -10 levels in patients with gastric cancer. Gastric Cancer 2009;12:95-100.   DOI
26 de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-1220.   DOI   ScienceOn
27 Iwakura Y, Nakae S, Saijo S, Ishigame H. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol Rev 2008;226:57-79.   DOI   ScienceOn
28 Kabir S. The role of interleukin-17 in the Helicobacter pylori induced infection and immunity. Helicobacter 2011;16:1-8.
29 Iida T, Iwahashi M, Katsuda M, Ishida K, Nakamori M, Nakamura M, et al. Prognostic significance of IL-17 mRNA expression in peritoneal lavage in gastric cancer patients who underwent curative resection. Oncol Rep 2014;31:605-612.   DOI
30 Hong DS, Angelo LS, Kurzrock R. Interleukin-6 and its receptor in cancer: implications for translational therapeutics. Cancer 2007;110:1911-1928.   DOI   ScienceOn
31 Gudis K, Sakamoto C. The role of cyclooxygenase in gastric mucosal protection. Dig Dis Sci 2005;50 Suppl 1:S16-S23.   DOI
32 Grosch S, Maier TJ, Schiffmann S, Geisslinger G. Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors. J Natl Cancer Inst 2006;98:736-747.   DOI   ScienceOn
33 Mao W, Chen J, Peng TL, Yin XF, Chen LZ, Chen MH. Helicobacter pylori infection and administration of non-steroidal anti-inflammatory drugs down-regulate the expression of gastrokine-1 in gastric mucosa. Turk J Gastroenterol 2012;23:212-219.   DOI
34 Resnick MB, Sabo E, Meitner PA, Kim SS, Cho Y, Kim HK, et al. Global analysis of the human gastric epithelial transcriptome altered by Helicobacter pylori eradication in vivo. Gut 2006;55:1717-1724.   DOI   ScienceOn
35 Kim O, Yoon JH, Choi WS, Ashktorab H, Smoot DT, Nam SW, et al. GKN2 contributes to the homeostasis of gastric mucosa by inhibiting GKN1 activity. J Cell Physiol 2014;229:762-771.   DOI   ScienceOn
36 Choi WS, Seo HS, Song KY, Yoon JH, Kim O, Nam SW, et al. Gastrokine 1 expression in the human gastric mucosa is closely associated with the degree of gastritis and DNA methylation. J Gastric Cancer 2013;13:232-241.   DOI   ScienceOn
37 Otto WR, Patel K, McKinnell I, Evans MD, Lee CY, Frith D, et al. Identification of blottin: a novel gastric trefoil factor family-2 binding protein. Proteomics 2006;6:4235-4245.   DOI   ScienceOn
38 Otto WR, Thim L. Trefoil factor family-interacting proteins. Cell Mol Life Sci 2005;62:2939-2946.   DOI
39 Du JJ, Dou KF, Peng SY, Wang WZ, Wang ZH, Xiao HS, et al. Down-regulated full-length novel gene GDDR and its effect on gastric cancer. Zhonghua Yi Xue Za Zhi 2003;83:1166-1168.
40 Dai J, Zhang N, Wang J, Chen M, Chen J. Gastrokine-2 is downregulated in gastric cancer and its restoration suppresses gastric tumorigenesis and cancer metastasis. Tumour Biol 2014;35:4199-4207.   DOI   ScienceOn
41 Oien KA, Vass JK, Downie I, Fullarton G, Keith WN. Profiling, comparison and validation of gene expression in gastric carcinoma and normal stomach. Oncogene 2003;22:4287-4300.   DOI   ScienceOn
42 Yoshikawa Y, Mukai H, Hino F, Asada K, Kato I. Isolation of two novel genes, down-regulated in gastric cancer. Jpn J Cancer Res 2000;91:459-463.   DOI
43 Chetty R, Naidoo R, Tarin M, Sitti C. Chromosome 2p, 3p, 5q and 18q status in sporadic gastric cancer. Pathology 2002;34:275-281.   DOI
44 Yoon JH, Seo HS, Choi SS, Chae HS, Choi WS, Kim O, et al. Gastrokine 1 inhibits the carcinogenic potentials of Helicobacter pylori CagA. Carcinogenesis 2014; in press.
45 Panani AD. Cytogenetic and molecular aspects of gastric cancer: clinical implications. Cancer Lett 2008;266:99-115.   DOI   ScienceOn
46 Noguchi T, Wirtz HC, Michaelis S, Gabbert HE, Mueller W. Chromosomal imbalances in gastric cancer. Correlation with histologic subtypes and tumor progression. Am J Clin Pathol 2001;115:828-834.   DOI   ScienceOn
47 Yuasa Y. Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer 2003;3:592-600.   DOI   ScienceOn
48 Nieto MA, Cano A. The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity. Semin Cancer Biol 2012;22:361-368.   DOI   ScienceOn
49 Durães C, Almeida GM, Seruca R, Oliveira C, Carneiro F. Biomarkers for gastric cancer: prognostic, predictive or targets of therapy? Virchows Arch 2014;464:367-378.   DOI   ScienceOn
50 Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE, et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 2005;436:123-127.   DOI   ScienceOn
51 Larue L, Bellacosa A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/ AKT pathways. Oncogene 2005;24:7443-7454.   DOI   ScienceOn
52 Yoon JH, Kang YH, Choi YJ, Park IS, Nam SW, Lee JY, et al. Gastrokine 1 functions as a tumor suppressor by inhibition of epithelial-mesenchymal transition in gastric cancers. J Cancer Res Clin Oncol 2011;137:1697-1704.   DOI
53 Chen P, Lingen M, Sonis ST, Walsh-Reitz MM, Toback FG. Role of AMP-18 in oral mucositis. Oral Oncol 2011;47:831-839.   DOI   ScienceOn
54 Walsh-Reitz MM, Huang EF, Musch MW, Chang EB, Martin TE, Kartha S, et al. AMP-18 protects barrier function of colonic epithelial cells: role of tight junction proteins. Am J Physiol Gastrointest Liver Physiol 2005;289:G163-G171.   DOI   ScienceOn
55 Pavone LM, Del Vecchio P, Mallardo P, Altieri F, De Pasquale V, Rea S, et al. Structural characterization and biological properties of human gastrokine 1. Mol Biosyst 2013;9:412-421.   DOI   ScienceOn
56 Mao W, Chen J, Peng TL, Yin XF, Chen LZ, Chen MH. Downregulation of gastrokine-1 in gastric cancer tissues and restoration of its expression induced gastric cancer cells to apoptosis. J Exp Clin Cancer Res 2012;31:49.   DOI
57 Sinclair NF, Ai W, Raychowdhury R, Bi M, Wang TC, Koh TJ, et al. Gastrin regulates the heparin-binding epidermal-like growth factor promoter via a PKC/EGFR-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 2004;286:G992-G999.   DOI   ScienceOn
58 Kouznetsova I, Laubinger W, Kalbacher H, Kalinski T, Meyer F, Roessner A, et al. Biosynthesis of gastrokine-2 in the human gastric mucosa: restricted spatial expression along the antral gland axis and differential interaction with TFF1, TFF2 and mucins. Cell Physiol Biochem 2007;20:899-908.   DOI   ScienceOn
59 Nardone G, Martin G, Rocco A, Rippa E, La Monica G, Caruso F, et al. Molecular expression of Gastrokine 1 in normal mucosa and in Helicobacter pylori-related preneoplastic and neoplastic gastric lesions. Cancer Biol Ther 2008;7:1890-1895.
60 Liao WC, Lin JT, Wu CY, Huang SP, Lin MT, Wu AS, et al. Serum interleukin-6 level but not genotype predicts survival after resection in stages II and III gastric carcinoma. Clin Cancer Res 2008;14:428-434.   DOI   ScienceOn
61 Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelialmesenchymal transitions in development and disease. Cell 2009;139:871-890.   DOI   ScienceOn
62 Yan GR, Xu SH, Tan ZL, Yin XF, He QY. Proteomics characterization of gastrokine 1-induced growth inhibition of gastric cancer cells. Proteomics 2011;11:3657-3664.   DOI   ScienceOn
63 Oien KA, McGregor F, Butler S, Ferrier RK, Downie I, Bryce S, et al. Gastrokine 1 is abundantly and specifically expressed in superficial gastric epithelium, down-regulated in gastric carcinoma, and shows high evolutionary conservation. J Pathol 2004;203:789-797.   DOI   ScienceOn